Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: fyi...the initial rejection of the 148 has been reversed..buying time IMO
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I agree. So why then after all the initial work and initial rejection does the PTO dig this up? Is it a matter of the PTO not doing a thorough job the first time or is this what the T3 are saying is the prior art?

Moore reversing the original rejection is very encouraging and IMO he will do it again.

All the best,

Steve

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply